APA (7th ed.) Citation

AC, W., KW, M., AL, T., L, G., & AK, F. (2020). Single-center pediatric experience with venetoclax and azacitidine as treatment for myelodysplastic syndrome and acute myeloid leukemia. Pediatric blood & cancer, 67(10), e28398. https://doi.org/10.1002/pbc.28398

Chicago Style (17th ed.) Citation

AC, Winters, Maloney KW, Treece AL, Gore L, and Franklin AK. "Single-center Pediatric Experience with Venetoclax and Azacitidine as Treatment for Myelodysplastic Syndrome and Acute Myeloid Leukemia." Pediatric Blood & Cancer 67, no. 10 (2020): e28398. https://doi.org/10.1002/pbc.28398.

MLA (9th ed.) Citation

AC, Winters, et al. "Single-center Pediatric Experience with Venetoclax and Azacitidine as Treatment for Myelodysplastic Syndrome and Acute Myeloid Leukemia." Pediatric Blood & Cancer, vol. 67, no. 10, 2020, p. e28398, https://doi.org/10.1002/pbc.28398.